CJC 1295 (No Dac)/ Ipamorelin Blend 5mg

CJC-1295 (No DAC) and Ipamorelin Blend (5mg + 5mg)

Explore the potential of our CJC-1295 (No DAC) and Ipamorelin Blend, a premium research peptide combination designed for advanced scientific studies. This blend contains 5mg of CJC-1295 (No DAC), a 29-amino-acid peptide that amplifies natural growth hormone (GH) release, and 5mg of Ipamorelin, a selective GH secretagogue known for its high specificity and minimal side effects. Together, they offer synergistic effects for investigating GH-related pathways in vitro and in laboratory settings.

Key Features:

• Composition: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin per vial.

• Mechanism: CJC-1295 (No DAC) binds to GHRH receptors to enhance pulsatile GH release, with a short half-life (30 minutes to 2 hours) for frequent dosing flexibility. Ipamorelin stimulates GH secretion via ghrelin receptor activation, promoting protein synthesis and cellular regeneration.

• Synergy: The blend maximizes GH and IGF-1 production, offering a potent tool for studying muscle growth, fat metabolism, and tissue repair.

Primary Research Applications:

• Muscle Growth and Repair: Investigated in animal models (e.g., rats) for promoting protein synthesis, muscle hypertrophy, and post-exercise recovery, making it ideal for studies on lean mass development.

• Fat Loss: Enhances lipolysis, targeting visceral fat breakdown, providing a valuable model for metabolic research when combined with controlled variables like diet and exercise.

• Anti-Aging: Elevates GH levels to explore improvements in cell regeneration, skin elasticity, and energy, addressing age-related decline in GH production.

• Bone Health: Supports studies on bone density and fracture recovery, with GH and IGF-1 stimulating bone formation in preclinical models.

• Sleep and Recovery: Investigated for its role in improving sleep quality and tissue regeneration, leveraging GH’s influence on the sleep-wake cycle and collagen production.

• Potential Medical Research: Explored for growth hormone deficiency, post-surgical healing, and chronic conditions like muscle wasting, offering a less invasive alternative to synthetic GH in lab settings.

Administration for Research:

• Delivery: Subcutaneous injection (e.g., abdomen or thigh) for in vitro or animal studies. Not viable for oral administration due to digestive breakdown.

• Dosage: Typical research protocols use 100-300 µg of the blend (combined CJC-1295 No DAC and Ipamorelin), 1-3 times daily, often timed at night to mimic natural GH pulses or pre/post-exercise for fitness-related studies. Cycles typically span 8-12 weeks.

• Storage: Store lyophilized powder at 2-8°C; reconstitute with bacteriostatic water for use in controlled lab environments.

Product Usage: This item is designed exclusively for use as a research chemical in laboratory settings and in vitro experiments, to be handled only by licensed, trained professionals. It is not intended or approved for human or animal consumption. Any misuse, misbranding, or mislabeling as a drug, food, or cosmetic is strictly forbidden. All accompanying information is provided solely for educational purposes.

Advance your research into longevity and performance with the CJC-1295 (No DAC) and Ipamorelin Blend. Order now to unlock new insights in GH-related studies.

👉 Learn more about peptides and their research use in our full peptide introduction guide.